Skip to main content

Regulatory and Washington

  • Express Scripts SEC filing: PBM expects to close Medco merger next week

    ST. LOUIS — The Federal Trade Commission's ruling on the Express Scripts and Medco merger may be imminent, Express Scripts noted in a Form 8-K filing to the Securities and Exchange Commission on Wednesday.

  • Community pharmacy coalition calls on state attorneys general to block PBM merger

    WASHINGTON — The Preserve Community Pharmacy Access NOW! coalition — formed in opposition of the proposed Express Scripts-Medco merger — Wednesday afternoon hosted a press conference making a direct appeal to attorneys general to block the ESI-Medco merger in the courts should the Federal Trade Commission approve the merger.

  • Three generic versions of psychiatric drug launched

    NEW YORK — Three companies have launched generic versions of a psychiatric drug made by AstraZeneca following a court decision turning down the Anglo-Swedish drug maker's request for an injunction against the Food and Drug Administration's approval of the generics.

    Dr. Reddy's Labs, Teva and Mylan announced Wednesday the launch of their respective versions of quetiapine fumarate tablets, generic formulations of AstraZeneca's Seroquel, in strengths ranging from 25 mg to 400 mg.

  • FDA approves Omontys for kidney disease-related anemia

    SILVER SPRING, Md. — The Food and Drug Administration has approved a new treatment for anemia in patients with chronic kidney disease.

    The FDA announced the approval of Affymax's Omontys (peginesatide), a drug belonging to the class known as erythropoiesis-stimulating agents, designed to aid the formation of red blood cells.

  • NACDS to Senate subcommittee: Help protect patient choice, preserve pharmacy access for Tricare beneficiaries

    ALEXANDRIA, Va. — The Senate Armed Services Subcommittee on Personnel on Wednesday held a hearing to discuss the fiscal year 2013 defense authorization.

  • NCPA releases program for Legislative Conference meeting

    ALEXANDRIA, Va. — The National Community Pharmacists Association on Monday released the program for its 2012 Legislative Conference meeting, which will bring community pharmacists and some of Washington, D.C.’s most senior decision-makers together to discuss pressing healthcare and pharmacy issues.
     

  • Giant-Carlisle to sponsor drug take-back event

    CARLISLE, Pa. — Giant-Carlisle will work with the Drug Enforcement Administration to sponsor several medication take-back events next month, the company said.

    The chain, owned by Netherlands-based Royal Ahold and officially known as Giant Food Stores, will work with the DEA and local law enforcement agencies as part of the national drug take-back initiative on April 28, collecting unwanted medications at several of its stores.

  • Sens. Tester, Moran, pharmacy groups gather to discuss role of pharmacists in rural America

    WASHINGTON — During a briefing held for the Senate Community Pharmacy Caucus, two senators and two pharmacy groups emphasized how pharmacists located in rural areas of the United States are playing an increasingly important role in delivering health care to their patients.

X
This ad will auto-close in 10 seconds